Evidence map›Paper›PMID 36702319›Full record

ArticleNeurobiology of disease2023

Hippocampal glucocorticoid receptors modulate status epilepticus severity.

Kimberly L Kraus, Nawshaba Nawreen, Christin M Godale, Arihant P Chordia, Ben Packard, Candi L LaSarge, James P Herman, Steve C Danzer

Open access · goldAbstract read
In one paragraph

Article in Neurobiology of disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kimberly L KrausMedical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Neuroscience Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America. Electronic address: krauskl@mail.uc.edu.
Nawshaba NawreenNeuroscience Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Pharmacology and Systems Physiology, University of Cincinnati School of Medicine, Cincinnati, OH, United States of America. Electronic address: nawreena@mail.uc.edu.
Christin M GodaleNeuroscience Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America. Electronic address: godalecm@mail.uc.edu.
Arihant P ChordiaDepartment of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America. Electronic address: chordiap@mail.uc.edu.
Ben PackardDepartment of Pharmacology and Systems Physiology, University of Cincinnati School of Medicine, Cincinnati, OH, United States of America. Electronic address: packarba@ucmail.uc.edu.
Candi L LaSargeNeuroscience Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Department of Anesthesiology, University of Cincinnati School of Medicine, Cincinnati, OH, United States of America.
James P HermanMedical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Anesthesiology, University of Cincinnati School of Medicine, Cincinnati, OH, United States of America. Electronic address: hermanjs@ucmail.uc.edu.
Steve C DanzerMedical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Neuroscience Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America; Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Department of Anesthesiology, University of Cincinnati School of Medicine, Cincinnati, OH, United States of America. Electronic address: steve.danzer@cchmc.org.
University of Cincinnati · USUniversity of Cincinnati Medical Center · USCincinnati Children's Hospital Medical Center · US

Funding

Selective disruption of hippocampal dentate granule cells in autism: impact of PTR01NS065020 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI DANZER, STEVE C · 2009 to 2023
$6.1M
mTOR regulation of aberrant neuronal integration and epileptogenesis in epilepsyR01NS062806 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI DANZER, STEVE C · 2009 to 2019
$3.6M
Anti-epileptogenic role of mTOR activation among hippocampal interneuronsR01NS121042 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI DANZER, STEVE C · 2022 to 2025
$2.0M
The Role of Raptor in Temporal Lobe EplieptogenesisF31NS115525 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI GODALE, CHRISTIN MARGARET · 2019 to 2022
$116k
Role of dentate granule cell glucocorticoid receptors in neuronal excitability and status epilepticusF31NS122484 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI KRAUS, KIMBERLY LYNN · 2021 to 2022
$79k
NINDS NIH HHS F31 NS115525NINDS NIH HHS F31 NS122484NINDS NIH HHS R01 NS062806NINDS NIH HHS R01 NS065020NINDS NIH HHS R01 NS121042
6 · The paper itself

Abstract

Status epilepticus (SE) is a life-threatening medical emergency with significant morbidity and mortality. SE is associated with a robust and sustained increase in serum glucocorticoids, reaching concentrations sufficient to activate the dense population of glucocorticoid receptors (GRs) expressed among hippocampal excitatory neurons. Glucocorticoid exposure can increase hippocampal neuron excitability; however, whether activation of hippocampal GRs during SE exacerbates seizure severity remains unknown. To test this, a viral strategy was used to delete GRs from a subset of hippocampal excitatory neurons in adult male and female mice, producing hippocampal GR knockdown mice. Two weeks after GR knockdown, mice were challenged with the convulsant drug pilocarpine to induce SE. GR knockdown had opposing effects on early vs late seizure behaviors, with sex influencing responses. For both male and female mice, the onset of mild behavioral seizures was accelerated by GR knockdown. In contrast, GR knockdown delayed the onset of more severe convulsive seizures and death in male mice. Concordantly, GR knockdown also blunted the SE-induced rise in serum corticosterone in male mice. GR knockdown did not alter survival times or serum corticosterone in females. To assess whether loss of GR affected susceptibility to SE-induced cell death, within-animal analyses were conducted comparing local GR knockdown rates to local cell loss. GR knockdown did not affect the degree of localized neuronal loss, suggesting cell-intrinsic GR signaling neither protects nor sensitizes neurons to acute SE-induced death. Overall, the findings reveal that hippocampal GRs exert an anti-convulsant role in both males and females in the early stages of SE, followed by a switch to a pro-convulsive role for males only. Findings reveal an unexpected complexity in the interaction between hippocampal GR activation and the progression of SE.

Indexed as

Receptors, GlucocorticoidStatus EpilepticusAnimalsConvulsantsCorticosteroneFemaleGlucocorticoidsHippocampusMaleMicePilocarpineSeizuresConvulsantsCorticosteroneGlucocorticoidsPilocarpineReceptors, GlucocorticoidDentate gyrusEpilepsyFluoro-Jade BHypothalamic-pituitary adrenal axisPilocarpineSeizure thresholdSex differences

Identifiers

PMID36702319
PMCPMC10055427
OpenAlexW4317754140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.